BET family members BRD2 and BRD4 are over expressed in melanoma and are able to be inhibited by a number of relatively novel drugs such as JQ-1 and I-BET151, leading to reduced melanoma growth, cell death and reduction in NF-κB activity [52,53,54,55]. The gene discussed is BRD2; the disease is melanoma.